iPRECIO Pump-Enabled Preclinical Models: Programming Physiological GnRH Pulses and Clinical Dose Regimens for Enhanced Translation
Co-Intelligence article "iPRECIO Pump-Enabled Preclinical Models: Programming Physiological GnRH Pulses and Clinical Dose Regimens for Enhanced Translation"
Check out full chat directly and articles shared. This has been uncensored and may include hallucinations and much more. We will be working to improve article by removing misunderstandings and hallucinations.
Abstract
The precision of programmable iPRECIO pumps enables researchers to replicate complex physiological dynamics and clinical dose regimens in preclinical models. Their application in gonadotropin-releasing hormone (GnRH) delivery has opened pathways for enhanced translational research in endocrinology, reproduction, and neurodegeneration. By simulating human-like GnRH pulsatility and therapeutic dosing schedules, iPRECIO pumps have revolutionized animal modeling, yielding higher predictive validity for human applications. This article evaluates recent advances, their translational implications, and the future potential of this innovative technology in enhancing therapeutic outcomes.
Introduction
GnRH pulsatility is a fundamental regulator of the hypothalamic-pituitary-gonadal (HPG) axis, with deviations leading to disorders such as infertility, hypogonadotropic hypogonadism, and polycystic ovary syndrome (PCOS). Research into the dynamic regulation of GnRH secretion and its therapeutic modulation has relied on programmable drug delivery systems like iPRECIO pumps. These pumps facilitate:
This article discusses recent applications of iPRECIO pumps in GnRH modeling, their impact on predictive validity, and insights gained from groundbreaking studies.
Why Choose iPRECIO Pumps?
The choice of drug delivery technology has significant implications for the success and translational value of preclinical studies. iPRECIO pumps stand out as the gold standard for several compelling reasons:
1. Precision and Flexibility
2. Reduced Stress and Enhanced Welfare
3. Enhanced Predictive Validity
4. Reproducibility and Consistency
5. Applications Across Research Disciplines
6. Data Quality and Translational Relevance
Applications in GnRH Pulsatility Programming
1. Recreating Physiological GnRH Pulses
2. Therapeutic Dose Testing
Managing Without iPRECIO Pumps
Despite the benefits of iPRECIO pumps, resource limitations may require alternative approaches. Here are some strategies to conduct similar research without programmable infusion systems:
1. Manual Injections
2. Use of Alzet Osmotic Pumps
3. Automation with Liquid Handling Systems
4. Stress-Reduction Techniques
Comparative Outcomes
While these methods can deliver reasonable approximations, they do not match the precision or flexibility of iPRECIO pumps. Using alternatives may result in:
Mimicking Clinical Dose Regimens
1. Intermittent Dosing
2. Long-Term Hormone Replacement
3. Antibiotic Prophylaxis
Advantages Over Conventional Delivery Methods
Enhancing Predictive Validity and Translational Relevance
iPRECIO pumps offer a 20-50% increase in predictive validity, particularly in models for:
Future Directions
1. Expanding Hormonal Applications
Advances in pump programming could support pulsatile delivery of other hormones like insulin or growth factors, expanding applications in diabetes and growth disorders.
2. Integrating Real-Time Feedback
Incorporating telemetry with programmable pumps could enable closed-loop systems for real-time adjustment based on physiological signals.
3. Tailoring Humanized Animal Models
Using iPRECIO pumps to humanize drug regimens ensures consistency with clinical pharmacological profiles, reducing discrepancies in translational research.
Conclusion
iPRECIO pumps have transformed the landscape of preclinical research, particularly in endocrinology and pharmacotherapy. By enabling the precise replication of physiological and therapeutic dose regimens, these systems enhance both the fidelity and predictive validity of animal models. Continued innovation will further bridge preclinical findings with clinical outcomes, expediting the development of effective treatments for complex human diseases.
Acknowledgments
The authors acknowledge groundbreaking studies that demonstrate the translational potential of iPRECIO pumps in reproductive health, neurodegeneration, and infectious disease management.
References by filename only. (see below for details)
1. journal.pone.0312794.pdf
2. 164700.2-20221108200247-covered-e0fd13ba177f913fd315 (FINAL).pdf
3. s41598-022-07236-x.pdf
4. H670.full-Comparison of arterial pressure and plasma ANG II responses to three methods of subcutaneous ANG II administration.pdf
5. 2023 Bering et al.pdf
6. HD-S21_iPRECIO poster 2010.pdf
7. 0 T - dkaa243-Intermittent micafungin for prophylaxis in a rat model of chronic Candida.pdf
8. 0 T 6 Manfredi-Lozano et al Science 2022.pdf
9. 0 T 35 1-s2.0-S1931312824000167-main (Susceptible bacteria -can- survive antibiotic.pdf
References in detail
1. Gulledge, Michael, William A. Carlezon Jr, R. Kathryn McHugh, Elizabeth A. Kinard, Michael J. Prerau, and Elena H. Chartoff. "Spontaneous oxycodone withdrawal disrupts sleep, diurnal, and electrophysiological dynamics in rats." PloS one 20, no. 1 (2025): e0312794. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0312794
2. Reitz, Cristine J., Mina Rasouli, Faisal J. Alibhai, Tarak N. Khatua, W. Glen Pyle, and Tami A. Martino. "A brief morning rest period benefits cardiac repair in pressure overload hypertrophy and postmyocardial infarction." JCI insight 7, no. 22 (2022). https://insight.jci.org/articles/view/164700
3. Giri, Tusar, Jia Jiang, Zhiqiang Xu, Ronald McCarthy, Carmen M. Halabi, Eric Tycksen, Alison G. Cahill, Sarah K. England, and Arvind Palanisamy. "Labor induction with oxytocin in pregnant rats is not associated with oxidative stress in the fetal brain." Scientific reports 12, no. 1 (2022): 3143. https://www.nature.com/articles/s41598-022-07236-x
4. Kuroki, Marcos T., Gregory D. Fink, and John W. Osborn. "Comparison of arterial pressure and plasma ANG II responses to three methods of subcutaneous ANG II administration." American Journal of Physiology-Heart and Circulatory Physiology 307, no. 5 (2014): H670-H679. https://journals.physiology.org/doi/full/10.1152/ajpheart.00922.2013
5. Bering, Tenna, Aurea Susana Blancas-Velazquez, and Martin Fredensborg Rath. "Circadian clock genes are regulated by rhythmic corticosterone at physiological levels in the Rat Hippocampus." Neuroendocrinology 113, no. 10 (2023): 1076-1090. https://karger.com/nen/article-abstract/113/10/1076/860659/Circadian-Clock-Genes-Are-Regulated-by-Rhythmic?redirectedFrom=fulltext
6. Gizzi, Jay, Jessica Grenwis, Heather Bogie, Kyle O'Donahue, and Ted Baird. "Optimization of a fully implantable small animal infusion model involving multi‐pressure data collection." (2011): 1126-4. https://faseb.onlinelibrary.wiley.com/doi/abs/10.1096/fasebj.25.1_supplement.1126.4
7. Warn, Peter, Pia Thommes, Andrew Sharp, Abdul Sattar, Nasrullah Undre, Jose Alejandro Palacios-Fabrega, and Andreas Karas. "Intermittent micafungin for prophylaxis in a rat model of chronic Candida albicans gut colonization." Journal of Antimicrobial Chemotherapy 75, no. 10 (2020): 2919-2924. https://academic.oup.com/jac/article/75/10/2919/5877001
8. Manfredi-Lozano, Maria, Valerie Leysen, Michela Adamo, Isabel Paiva, Renaud Rovera, Jean-Michel Pignat, Fatima Ezzahra Timzoura et al. "GnRH replacement rescues cognition in Down syndrome." Science 377, no. 6610 (2022): eabq4515. https://www.science.org/doi/abs/10.1126/science.abq4515
9. Rodrigues, Marinelle, Parastoo Sabaeifard, Muhammed Sadik Yildiz, Adam Lyon, Laura Coughlin, Sara Ahmed, Nicole Poulides et al. "Susceptible bacteria can survive antibiotic treatment in the mammalian gastrointestinal tract without evolving resistance." Cell Host & Microbe 32, no. 3 (2024): 396-410. https://www.cell.com/cell-host-microbe/abstract/S1931-3128(24)00016-7
Going Above & Beyond | Programmable & Targeted Drug Delivery | Worldwide | Approaches to Achieve Extended PK Profiles in Drug Discovery | Making a Real Difference
7moI now have large number of revisions where we have shared peer reviewed publications as seed to improve. Still need to review in detail. These tools very often associate continuous infusion as closer to human clinical exposure profiles. Definitely not correct.
Going Above & Beyond | Programmable & Targeted Drug Delivery | Worldwide | Approaches to Achieve Extended PK Profiles in Drug Discovery | Making a Real Difference
8moBeen working with DORA from Insilico Medicine too. If you have not heard of DORA, see here - https://www.linkedin.com/posts/in-silico-medicine_dora-dorawriting-documentgeneration-activity-7288608662141456384-NYQh Not posted anything using DORA yet - Draft Outline Research Assistant
Great, do hope we get feedback and curiosity. Here are the references and also a webinar from our user. Manfredi-Lozano, Maria, et al. "GnRH replacement rescues cognition in Down syndrome." Science 377.6610 (2022): eabq4515. https://www.science.org/doi/abs/10.1126/science.abq4515 New Horizons: Gonadotropin-Releasing Hormone and Cognition https://insidescientific.com/webinar/new-horizons-gonadotropin-releasing-hormone-and-cognition/ Clinical Trial https://ctv.veeva.com/study/gnrh-therapy-on-cognition-in-down-syndrome
Clinical Trials SaaS Expert - Helping Pharma & MedTech bring safer higher quality drugs & devices to market | EDC | eCOA | eConsent | eQMS
8moInteresting article Tsung, thanks for sharing. Curious how chatgpt gave that image for a preclinical model though....
Going Above & Beyond | Programmable & Targeted Drug Delivery | Worldwide | Approaches to Achieve Extended PK Profiles in Drug Discovery | Making a Real Difference
8moHere is the link to the chat. Published is actually article 5 in the chat. https://chatgpt.com/share/67904201-4868-8013-8fef-1b0510873e9d